--- title: "InfinityRx Named #2 Fastest-Growing Company in the Northeast on the 2026 Inc. Regionals List" description: "InfinityRx is named #2 fastest-growing company in the Northeast on the 2026 Inc. Regionals list, reflecting its growth since 2021." --- InfinityRx made the 2026 Inc. 5000 list. [See our Inc. 5000 ranking](https://www.infinityrx.com/news-insights/infinityrx-named-to-2026-inc5000) [![infinityrx-white](https://www.infinityrx.com/hs-fs/hubfs/Logos/infinityrx-white.png?width=512&height=392&name=infinityrx-white.png)](https://www.infinityrx.com) - [Solutions](https://www.infinityrx.com/solutions) [Claims Program Administration Pharmacy and medical benefit copay through one proprietary engine.](https://www.infinityrx.com/solutions#powered-by-icp) [Access Services Verify coverage. Accelerate access.](https://www.infinityrx.com/solutions#powered-by-icp) [GTN Protection Protect access. Protect every affordability dollar.](https://www.infinityrx.com/solutions#powered-by-icp) [Data & Program Intelligence Turn claims, access, and spend data into better program decisions.](https://www.infinityrx.com/solutions#powered-by-icp) [Patient Engagement Connected communications throughout the therapy journey.](https://www.infinityrx.com/solutions#powered-by-icp) See what your affordability program isn't telling you A structured read on leakage, speed, and claim-level visibility across your portfolio. [Request a Program Assessment](https://www.infinityrx.com/request-program-assessment) [Submit an RFP →](https://www.infinityrx.com/rfp-submission) - [Insights](https://www.infinityrx.com/news-insights) [All Articles For the teams running patient access programs](https://www.infinityrx.com/news-insights) [Benefit-to-WAC Ratio Understand program stability through Benefit-to-WAC ratio](https://www.infinityrx.com/news-insights/understanding-program-sustainability-through-benefit-to-wac-ratio) [Pharmacy Monitoring Why Real-Time Visibility Beats Reactive Audits](https://www.infinityrx.com/news-insights/pharmacy-monitoring-real-time-visibility) [Unified Dual Benefit Why Pharmacy and Medical Benefits Belong on One Platform](https://www.infinityrx.com/news-insights/unified-dual-benefit-why-pharmacy-and-medical-belong-on-one-platform) [Under-Reimbursement The Gross-to-Net Leak Most Manufacturers Don't See](https://www.infinityrx.com/news-insights/under-reimbursement-the-gross-to-net-leak-most-manufacturers-dont-see) [InfinityRx named No. 156 on the 2026 Inc. 5000 list Read the announcement](https://www.infinityrx.com/news-insights/infinityrx-named-to-2026-inc5000) - [About Us](https://www.infinityrx.com/about) - [Contact Us](https://www.infinityrx.com/contact) [Request a Program Assessment](https://www.infinityrx.com/request-program-assessment) Solutions [Solutions overview](https://www.infinityrx.com/solutions) [Claims Program Administration](https://www.infinityrx.com/solutions#powered-by-icp) [Access Services](https://www.infinityrx.com/solutions#powered-by-icp) [GTN Protection](https://www.infinityrx.com/solutions#powered-by-icp) [Data & Program Intelligence](https://www.infinityrx.com/solutions#powered-by-icp) [Patient Engagement](https://www.infinityrx.com/solutions#powered-by-icp) Insights [Insights overview](https://www.infinityrx.com/news-insights) [All Articles](https://www.infinityrx.com/news-insights) [Benefit-to-WAC Ratio](https://www.infinityrx.com/news-insights/understanding-program-sustainability-through-benefit-to-wac-ratio) [Pharmacy Monitoring](https://www.infinityrx.com/news-insights/pharmacy-monitoring-real-time-visibility) [Unified Dual Benefit](https://www.infinityrx.com/news-insights/unified-dual-benefit-why-pharmacy-and-medical-belong-on-one-platform) [Under-Reimbursement](https://www.infinityrx.com/news-insights/under-reimbursement-the-gross-to-net-leak-most-manufacturers-dont-see) [About Us](https://www.infinityrx.com/about) [Contact Us](https://www.infinityrx.com/contact) [Request a Program Assessment](https://www.infinityrx.com/request-program-assessment) # InfinityRx Named #2 Fastest-Growing Company in the Northeast on the 2026 Inc. Regionals List [InfinityRx](https://www.infinityrx.com/news-insights/author/infinityrx) Apr 4, 2026 --- [Award](https://www.infinityrx.com/news-insights/tag/award) [Press Release](https://www.infinityrx.com/news-insights/tag/press-release) **Westbury, NY — March 15, 2026** — InfinityRx has been named #2 on the 2026 Inc. Regionals Northeast list, ranking among the fastest-growing private companies in the region. The recognition reflects InfinityRx's revenue trajectory since its founding in 2021 and its expanding footprint in pharmaceutical patient support services.     Inc. Regionals highlights the most successful private companies across eight regions of the United States, measured by verified revenue growth over a three-year period. The Northeast list covers Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont — one of the most competitive regional rankings in the Inc. ecosystem. ## The Growth Story InfinityRx's inclusion in the top tier of the Inc. Regionals Northeast list reflects: - 450–500% revenue growth since 2022 - 8 million-plus claims processed through the InfinityRx platform - $1.5 billion-plus in patient benefit administered - 15+ program transitions delivered with zero patient disruption in the past year - $17 million in maximizer savings recovered for manufacturer clients - $50 million recovered across 85,000 previously under-reimbursed claims The company's growth has been driven by pharmaceutical manufacturer adoption of its patent-protected claims adjudication platform, which consolidates the functions historically performed by five to seven separate vendors onto a single owned infrastructure. ## A Statement from the Founder "Being named #2 in the Northeast is a serious milestone for a company that started in 2021 with a patent, a thesis, and a belief that the vendor stack running patient support had outlived its usefulness," said Greg Savino, PharmD, Co-Founder and CEO of InfinityRx. "The growth isn't the product — the product is what we're building for pharma manufacturers, and their patients. The growth is the market telling us that what we're building is what they've been waiting for." "This is also personal," Savino added. "In 2019, I had the privilege of taking Baybridge Pharmacy to the Inc. 5000 as the #46 fastest-growing healthcare company in the country. Returning to the Inc. family six years later with a technology company ranked #2 in the Northeast tells me the thesis was right — that patient support needed new infrastructure, not new vendors." ## About InfinityRx InfinityRx is an administrator for copay assistance programs that uses proprietary technology to deliver progressive, efficient, and cost-effective Patient Support Programs for pharmaceutical and biotech manufacturers. Founded in 2021 and headquartered in Westbury, New York, the company owns and operates its patent-protected claims adjudication platform end-to-end — unifying pharmacy and medical adjudication, copay program administration, accumulator and maximizer defense, and real-time analytics on a single intelligent infrastructure. Learn more at [infinityrx.com](https://www.infinityrx.com/). ## About Inc. Regionals Inc. Regionals is the Inc. media family's annual ranking of the fastest-growing private companies across eight regions of the United States. The list is compiled from verified revenue growth data reported by each company over a three-year measurement window. Inclusion is considered one of the most prestigious recognitions for private companies in each region. Learn more at [inc.com/regionals](https://www.inc.com/inc5000/regionals). --- ### Media Contact [press@infinityrx.com](mailto:press@infinityrx.com) InfinityRx 1600 Stewart Avenue, Suite 404 Westbury, NY 11590 888-927-3499 — ### — ## Related Insights [![InfinityRx named No. 156 on the 2026 Inc. 5000 list](https://www.infinityrx.com/hs-fs/hubfs/InfinityRx%20Inc5000%20Announcement%20Graphic.jpg?width=650&height=364&name=InfinityRx%20Inc5000%20Announcement%20Graphic.jpg)](https://www.infinityrx.com/news-insights/infinityrx-named-to-2026-inc5000) Award ### [InfinityRx named No. 156 on the 2026 Inc. 5000 list](https://www.infinityrx.com/news-insights/infinityrx-named-to-2026-inc5000) Award ### [InfinityRx Wins Gold at the 2024 American Business Awards® for Technical Support Strategy & Implementation](https://www.infinityrx.com/news-insights/infinityrx-wins-gold-at-the-2024-american-business-awards-for-technical-support-strategy-implementation) Award ### [InfinityRx Wins Bronze at the 2025 American Business Awards® for Customer Service Success](https://www.infinityrx.com/news-insights/infinityrx-wins-bronze-at-the-2025-american-business-awards-for-customer-service-success) [![InfinityRx](https://www.infinityrx.com/hs-fs/hubfs/InfinityRx%20logo%20white.png?width=300&height=52&name=InfinityRx%20logo%20white.png "InfinityRx")](https://infinityrx.com) InfinityRx helps pharmaceutical manufacturers administer pharmacy and medical benefit affordability programs, protect GTN performance, and turn claim-level data into better program decisions through InfinityRx Claims Processor®, the adjudication engine we own.  Built in New York. Explore - [Solutions](https://www.infinityrx.com/solutions) - [Insights](https://www.infinityrx.com/news-insights) - [Submit an RFP](https://www.infinityrx.com/rfp-submission) - [Request a Program Assessment](https://www.infinityrx.com/request-program-assessment) Company - [About Us](https://www.infinityrx.com/about) - [Contact Us](https://www.infinityrx.com/contact) - [Careers](https://www.linkedin.com/company/infinityrx/jobs) - [Follow Us](https://www.linkedin.com/company/infinityrx) SOC 2 · Type I + Type II Security, Availability, Confidentiality SOC 1 · Type I + Type II Financial Reporting Controls HIPAA Compliant PHI Handling Framework · Full Audit Logging --- © InfinityRx, LLC | All rights reserved. [Terms of Use](https://www.infinityrx.com/terms-of-use) • [Privacy Policy](https://www.infinityrx.com/privacy-policy) • [Cookie Policy](https://www.infinityrx.com/cookies-policy) • [Do Not Sell My Personal Information](https://www.infinityrx.com/do-not-sell-my-personal-data) • [Accessibility](https://www.infinityrx.com/accessibility) ![back-to-top](https://f.hubspotusercontent00.net/hubfs/7712601/back-to-top.png) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InfinityRx", "url" : "https://www.infinityrx.com/news-insights/author/infinityrx" }, "dateModified" : "2026-09-23T18:06:54.638Z", "datePublished" : "2026-04-04T13:00:00.000Z", "headline" : "InfinityRx Named #2 Fastest-Growing Company in the Northeast on the 2026 Inc. Regionals List", "mainEntityOfPage" : { "@id" : "https://www.infinityrx.com/news-insights/infinityrx-named-2-fastest-growing-company-in-the-northeast-on-the-2026-inc.-regionals-list", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.infinityrx.com/hubfs/infinityrx_logo_black.png" } } } ``` ```json { "@context" : "https://schema.org", "@type" : "Organization", "logo" : "https://www.infinityrx.com/hubfs/infinityrx_logo_black.png", "name" : "InfinityRx", "sameAs" : [ "https://www.linkedin.com/company/infinityrx" ], "url" : "https://www.infinityrx.com" } ```